Delta Electronics Inc (台達電) is to invest up to NT$13.2 billion (US$426.4 million) in Taiwan over the next three years in accordance with the global layout strategy of the power and thermal solutions provider.
The investment also demonstrates the company’s efforts to make Taiwan a main research and development (R&D) base, Delta official Johnny Shih (施孟璁) told the Taipei Times by telephone on Thursday.
The company is to recruit up to 1,800 people this year, with the majority being R&D engineering posts, Shih said.
Delta also plans to offer several thousand additional jobs in the next few years, he said, without providing an exact number.
“Delta is to diversify risk by moving investments back to Taiwan in light of the US-China trade war. The company’s latest move also provides an alternative production location for clients who care about information security, while helping increase its research and development capability,” Taishin Securities Investment Advisory Co (台新投顧) said in a note.
Delta three weeks ago approved a NT$2.57 billion investment to purchase buildings and land in Tao-
yuan’s Jhongli District (中壢) next to another plot of land it purchased last year for NT$2.1 billion.
Since last year, the company has divided investment equally between constructing new plants at Central Taiwan Science Park (中部科學園區) and Southern Taiwan Science Park (南部科學園區), as it is among the Taiwanese firms relocating production sites from China due to the US-China trade dispute.
Delta is boosting production in Thailand through the recent acquisition of a 63.78 percent stake in Delta Electronics (Thailand) PCL (泰達電) and is also looking to expand to India, it said.
In a recent interview with Bloomberg, Delta chief executive officer Cheng Ping (鄭平) said that the company plans to build three or four plants in India, with products manufactured there to be mainly for that market.
The plants in India would be managed by Delta Electronics (Thailand), Shih said.
At an investors’ conference on April 30, Delta chairman Yancey Hai (海英俊) said that the company would keep 80 percent of its production capacity in China, as it remains one of the world’s biggest markets.
The company reported cumulative revenue of NT$77.53 billion in the first four months, up 12.13 percent from NT$69.14 billion in the same period last year.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update